Kyverna Therapeutics, Inc. KYTX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s change in lease liabilities?
- Kyverna Therapeutics, Inc. (KYTX) reported change in lease liabilities of -$503K in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Kyverna Therapeutics, Inc.'s change in lease liabilities increased by 47.8% year-over-year, from -$963K to -$503K.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s change in lease liabilities?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s change in lease liabilities has grown at a 41.0% compound annual growth rate (CAGR), from -$1.68M to -$3.34M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.